471 related articles for article (PubMed ID: 31351413)
1. The role of complement in IgA nephropathy.
Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
[TBL] [Abstract][Full Text] [Related]
2. Role of complement in IgA nephropathy.
Daha MR; van Kooten C
J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
[TBL] [Abstract][Full Text] [Related]
3. A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
Gutiérrez E; Carvaca-Fontán F; Luzardo L; Morales E; Alonso M; Praga M
Nephron; 2020; 144(11):555-571. PubMed ID: 32818944
[TBL] [Abstract][Full Text] [Related]
4. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
[TBL] [Abstract][Full Text] [Related]
5. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
Zhu L; Guo WY; Shi SF; Liu LJ; Lv JC; Medjeral-Thomas NR; Lomax-Browne HJ; Pickering MC; Zhang H
Kidney Int; 2018 Jul; 94(1):150-158. PubMed ID: 29759419
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.
Rizk DV; Maillard N; Julian BA; Knoppova B; Green TJ; Novak J; Wyatt RJ
Front Immunol; 2019; 10():504. PubMed ID: 30941137
[TBL] [Abstract][Full Text] [Related]
7. Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy.
Medjeral-Thomas NR; O'Shaughnessy MM
Adv Chronic Kidney Dis; 2020 Mar; 27(2):111-119. PubMed ID: 32553243
[TBL] [Abstract][Full Text] [Related]
8. The role of secretory IgA and complement in IgA nephropathy.
Oortwijn BD; Eijgenraam JW; Rastaldi MP; Roos A; Daha MR; van Kooten C
Semin Nephrol; 2008 Jan; 28(1):58-65. PubMed ID: 18222347
[TBL] [Abstract][Full Text] [Related]
9. Role of podocyte injury in IgA nephropathy.
Menon MC; Chuang PY; He JC
Contrib Nephrol; 2013; 181():41-51. PubMed ID: 23689566
[TBL] [Abstract][Full Text] [Related]
10. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
11. Complement activation is associated with crescent formation in IgA nephropathy.
Itami H; Hara S; Samejima K; Tsushima H; Morimoto K; Okamoto K; Kosugi T; Kawano T; Fujiki K; Kitada H; Hatakeyama K; Tsuruya K; Ohbayashi C
Virchows Arch; 2020 Oct; 477(4):565-572. PubMed ID: 32300880
[TBL] [Abstract][Full Text] [Related]
12. IgA production and tonsillar focal infection in IgA nephropathy.
Meng H; Ohtake H; Ishida A; Ohta N; Kakehata S; Yamakawa M
J Clin Exp Hematop; 2012; 52(3):161-70. PubMed ID: 23269075
[TBL] [Abstract][Full Text] [Related]
13. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
[TBL] [Abstract][Full Text] [Related]
14. The complement system in IgAN: mechanistic context for therapeutic opportunities.
Duval A; Caillard S; Frémeaux-Bacchi V
Nephrol Dial Transplant; 2023 Nov; 38(12):2685-2693. PubMed ID: 37385820
[TBL] [Abstract][Full Text] [Related]
15. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
[TBL] [Abstract][Full Text] [Related]
16. New insights into the pathogenesis of IgA nephropathy.
Floege J; Moura IC; Daha MR
Semin Immunopathol; 2014 Jul; 36(4):431-42. PubMed ID: 24442210
[TBL] [Abstract][Full Text] [Related]
17. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
18. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
Medjeral-Thomas NR; Lomax-Browne HJ; Beckwith H; Willicombe M; McLean AG; Brookes P; Pusey CD; Falchi M; Cook HT; Pickering MC
Kidney Int; 2017 Oct; 92(4):942-952. PubMed ID: 28673452
[TBL] [Abstract][Full Text] [Related]
19. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.
Takahata A; Arai S; Hiramoto E; Kitada K; Kato R; Makita Y; Suzuki H; Nakata J; Araki K; Miyazaki T; Suzuki Y
J Am Soc Nephrol; 2020 Sep; 31(9):2013-2024. PubMed ID: 32611589
[TBL] [Abstract][Full Text] [Related]
20. Activation of complement in IgA nephropathy.
Wyatt RJ; Julian BA
Am J Kidney Dis; 1988 Nov; 12(5):437-42. PubMed ID: 3055972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
